For research use only. Not for therapeutic Use.
Zelminemab（Cat No.:I042138）is an investigational monoclonal antibody that targets the protein tau, which forms abnormal tangles in the brains of individuals with neurodegenerative diseases like Alzheimer’s disease. Tau aggregation is associated with cognitive decline and neuronal damage. By binding to tau, zelminemab aims to prevent the formation of these tangles or promote their clearance, potentially slowing disease progression and preserving cognitive function. It is being studied in clinical trials for its potential to treat Alzheimer’s disease and other tauopathies, with the goal of improving memory, cognition, and quality of life in affected patients.
| Catalog Number | I042138 |
| CAS Number | 2225850-33-7 |
| Purity | ≥95% |
